Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,279 INR | +0.38% | -1.52% | -5.69% |
05-06 | Caplin Point Laboratories Gets Colombian Drug Regulator's Approval for Soft Gel Capsules Unit in India | MT |
04-16 | Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.69% | 1.16B | |
+19.76% | 42.97B | |
+24.52% | 22.49B | |
+16.41% | 14.93B | |
+11.57% | 13.14B | |
+43.20% | 11.67B | |
-8.84% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.54B |
- Stock Market
- Equities
- CAPLIPOINT Stock
- News Caplin Point Laboratories Limited
- Caplin Point Unit Receives US FDA Nod for Eye Treatment Medication